Crescita Therapeutics Inc. (TSE:CTX – Get Free Report)’s stock price traded down 2.3% during trading on Thursday . The stock traded as low as C$0.43 and last traded at C$0.43. 4,515 shares traded hands during trading, a decline of 74% from the average session volume of 17,152 shares. The stock had previously closed at C$0.44.
Crescita Therapeutics Stock Performance
The company has a market capitalization of C$8.40 million, a PE ratio of -4.30 and a beta of 1.66. The company has a debt-to-equity ratio of 6.66, a quick ratio of 2.29 and a current ratio of 3.80. The business has a fifty day moving average price of C$0.42 and a 200 day moving average price of C$0.47.
About Crescita Therapeutics
Crescita Therapeutics Inc, a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel for the development of topicals containing cannabis and hemp.
Read More
- Five stocks we like better than Crescita Therapeutics
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- MarketBeat Week in Review – 4/22 – 4/26
- How to Invest in Biotech Stocks
- 3 Stocks Leading the U.S. Agriculture Comeback
- Dividend Payout Ratio Calculator
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Crescita Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescita Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
